RapiPlex for cutting-edge point of care diagnostics
Biosensia’s proprietary RapiPlex platform integrates three technologies:
A multi-channel fluidic chip
Robust, well-established fluorescence immunoassay systems
An integrated optical reader, providing numerical read-outs without the need for user interpretation
RapiPlex can be used for multiple point of care analytical applications, including infectious diseases, drugs of abuse (DOA) testing and cardiac markers. Other applications range through food and environment to clinical and security.